The GMC issued guidance to today that explicitly states that Doctors must not prescribe cosmetic injectables remotely. Instead a face-to face consultation with your prescriber must take place so that a medical history and examination can take place. It’s always been the position of the GMC that remote prescribing should be performed under exceptional circumstances, however, it seems that some have been exploiting the previous guidance in aesthetic practice.
For patients this an important step to improve safety. It means that you can undergo a proper evaluation of your medical history and an examination to determine if the treatment is safe and right for you, and that you have an opportunity to ask questions.
However, it may add a delay to your initial treatment depending on your practitioner. However, that isn’t always a bad thing and fits in with GMC guidance on the consent process, by giving you time to properly assess the risks and be sure that it what you want.
For non-presribing aesthetic practitioners it means finding a prescriber who can first see your patient/client and then provide the prescription. Unsurprisingly, this is likely to come at an additional cost for their time and the prescription.
The GDC and NMC have previously made statements that remote prescribing should not be used for these purposes.
GMC Guidance comes into effect from 23/7/2012